9 results found
https://www.federalregister.gov/documents/2022/11/23/2022-23918/medicare-program-hospital-…

…gible to be reclassified under Medicare Geographic Classification Review Board (MGCRB) reclassification process. Response: Pursuant to section 1861(kkk)(2)(B) of the Act, REHs may not provide acute care inpatient hospital services other than post-hospital extended care services f…

https://www.federalregister.gov/documents/2020/12/29/2020-26819/medicare-program-hospital-…

…al commenters requested that the drug Omidria, CPT J1097, ( phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml ), be excluded from the OPPS policy to package drugs that function as surgical supplies once its pass-through status expires on Sept…

https://www.federalregister.gov/public-inspection/2024-25521/medicare-and-medicaid-program…

…C packaging, such as Casgevy, Lyfgenia, Amtagvi, Omisurge, Zynteglo, Obe-cel, Hemgenix, Beqvez, Roctavian, Spinraza and Elevidys. A few commenters suggested CMS should review and identify any other products that may be administered as independent therapies in the hospital outpati…

https://www.federalregister.gov/documents/2025/08/04/2025-14681/medicare-program-hospital-…

…)(8)(E) of the Act, Implemented at § 412.103 2. General Policies and Effects of MGCRB Reclassification and Treatment of Dual Reclassified Hospitals 3. MGCRB Reclassification Issues for FY 2026 a. FY 2026 Reclassification Application Requirements and Approvals b. Revisions to § 41…